Human Angiopoietin-2 Quantikine ELISA Kit
| Name | Human Angiopoietin-2 Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DANG20 |
| Category | ELISA Kit |
| Prices | $519.00, $2,491.00, $16,868.00 |
| Sizes | 1 kit, 1 pack (6 Plates), 1 pack (50 Plates) |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (50 uL), Serum (10 uL), EDTA Plasma (10 uL), Heparin Plasma (10 uL), Saliva (50 uL) |
| Sensitivity | 21.3 pg/mL |
| Range | 46.9 - 3,000 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma, Saliva) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human Angiopoietin-2 Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human Angiopoietin-2 in cell culture supernates, serum, plasma, and saliva |
| Gene | ANGPT2 |
| Supplier Page | Shop |
Product images
Product References
Serum Concentrations of Angiopoietin-2 and Soluble fms-Like Tyrosine Kinase 1 - Serum Concentrations of Angiopoietin-2 and Soluble fms-Like Tyrosine Kinase 1
Dumnicka P, Kusnierz-Cabala B, Sporek M, Mazur-Laskowska M, Gil K, Kuzniewski M, Ceranowicz P, Warzecha Z, Dembinski A, Bonior J, Drozdz R. Int J Mol Sci. 2017 Apr 2;18(4). pii: E753.
Neovascularization Potential of Blood Outgrowth Endothelial Cells From Patients - Neovascularization Potential of Blood Outgrowth Endothelial Cells From Patients
Dauwe D, Pelacho B, Wibowo A, Walravens AS, Verdonck K, Gillijns H, Caluwe E, Pokreisz P, van Gastel N, Carmeliet G, Depypere M, Maes F, Vanden Driessche N, Droogne W, Van Cleemput J, Vanhaecke J, Prosper F, Verfaillie C, Luttun A, Janssens S. J Am Heart Assoc. 2016 Apr 18;5(4):e002288.
Angiopoietin-2, Angiopoietin-1 and subclinical cardiovascular disease in Chronic - Angiopoietin-2, Angiopoietin-1 and subclinical cardiovascular disease in Chronic
Tsai YC, Lee CS, Chiu YW, Kuo HT, Lee SC, Hwang SJ, Kuo MC, Chen HC. Sci Rep. 2016 Dec 19;6:39400.
TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by - TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by
Hossain MB, Shifat R, Johnson DG, Bedford MT, Gabrusiewicz KR, Cortes-Santiago N, Luo X, Lu Z, Ezhilarasan R, Sulman EP, Jiang H, Li SS, Lang FF, Tyler J, Hung MC, Fueyo J, Gomez-Manzano C. Sci Adv. 2016 Apr 1;2(4):e1501290. eCollection 2016 Apr.
Human neural stem cell-induced endothelial morphogenesis requires - Human neural stem cell-induced endothelial morphogenesis requires
Chou CH, Modo M. Sci Rep. 2016 Jul 4;6:29029.
Mechanism of angiopoietin-1 upregulation in Kaposi's sarcoma-associated - Mechanism of angiopoietin-1 upregulation in Kaposi's sarcoma-associated
Zheng X, Ohsaki E, Ueda K. J Virol. 2015 May;89(9):4786-97.
Angiopoietin/Tie2 Dysbalance Is Associated with Acute Kidney Injury after Cardiac - Angiopoietin/Tie2 Dysbalance Is Associated with Acute Kidney Injury after Cardiac
Jongman RM, van Klarenbosch J, Molema G, Zijlstra JG, de Vries AJ, van Meurs M. PLoS One. 2015 Aug 26;10(8):e0136205.
A randomized phase II study of capecitabine-based chemoradiation with or without - A randomized phase II study of capecitabine-based chemoradiation with or without
Salazar R, Capdevila J, Laquente B, Manzano JL, Pericay C, Villacampa MM, Lopez C, Losa F, Safont MJ, Gomez A, Alonso V, Escudero P, Gallego J, Sastre J, Gravalos C, Biondo S, Palacios A, Aranda E. BMC Cancer. 2015 Feb 26;15:60.
Kidney function, endothelial activation and atherosclerosis in black and white - Kidney function, endothelial activation and atherosclerosis in black and white
Dessein PH, Hsu HC, Tsang L, Millen AM, Woodiwiss AJ, Norton GR, Solomon A, Gonzalez-Gay MA. PLoS One. 2015 Mar 25;10(3):e0121693.
Combining bevacizumab and chemoradiation in rectal cancer. Translational results - Combining bevacizumab and chemoradiation in rectal cancer. Translational results
Verstraete M, Debucquoy A, Dekervel J, van Pelt J, Verslype C, Devos E, Chiritescu G, Dumon K, D'Hoore A, Gevaert O, Sagaert X, Van Cutsem E, Haustermans K. Br J Cancer. 2015 Apr 14;112(8):1314-25.